STING is an intrinsic checkpoint inhibitor that restrains the TH17 cell pathogenic program (2022)
- Authors:
- USP affiliated authors: NASCIMENTO, DANIELE CARVALHO BERNARDO - FMRP ; OLIVEIRA, SERGIO COSTA - ICB ; CUNHA, THIAGO MATTAR - FMRP ; CUNHA, FERNANDO DE QUEIROZ - FMRP ; ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; DAMASCENO, LUIS EDUARDO ALVES - FMRP ; CEBINELLI, GUILHERME CESAR MARTELOSSI - FMRP ; PÚBLIO, GABRIEL AZEVEDO - FMRP
- Unidades: FMRP; ICB
- DOI: 10.1016/j.celrep.2022.110838
- Subjects: CÉLULAS CULTIVADAS; INTERLEUCINA 10; TRANSDUÇÃO DE SINAL CELULAR
- Keywords: AhR; CP: Immunology; IL-10; IRF3; Rorγt; STING; T(H)17 cells; Pathogenicity
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Cell Reports
- ISSN: 2211-1247
- Volume/Número/Paginação/Ano: v. 39, n. 8, art. 110838, p. 1-16, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
DAMASCENO, Luis Eduardo Alves et al. STING is an intrinsic checkpoint inhibitor that restrains the TH17 cell pathogenic program. Cell Reports, v. 39, n. 8, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.celrep.2022.110838. Acesso em: 29 dez. 2025. -
APA
Damasceno, L. E. A., Cebinelli, G. C. M., Fernandes, M. F., Nascimento, D. C., Públio, G. A., Vinolo, M. A. R., et al. (2022). STING is an intrinsic checkpoint inhibitor that restrains the TH17 cell pathogenic program. Cell Reports, 39( 8), 1-16. doi:10.1016/j.celrep.2022.110838 -
NLM
Damasceno LEA, Cebinelli GCM, Fernandes MF, Nascimento DC, Públio GA, Vinolo MAR, Oliveira SC, Sparwasser T, Cunha TM, Cunha F de Q, Alves Filho JCF. STING is an intrinsic checkpoint inhibitor that restrains the TH17 cell pathogenic program [Internet]. Cell Reports. 2022 ; 39( 8): 1-16.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.celrep.2022.110838 -
Vancouver
Damasceno LEA, Cebinelli GCM, Fernandes MF, Nascimento DC, Públio GA, Vinolo MAR, Oliveira SC, Sparwasser T, Cunha TM, Cunha F de Q, Alves Filho JCF. STING is an intrinsic checkpoint inhibitor that restrains the TH17 cell pathogenic program [Internet]. Cell Reports. 2022 ; 39( 8): 1-16.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1016/j.celrep.2022.110838 - CCR2-deficient mice are protected to sepsis by the disruption of the inflammatory monocytes emigration from the bone marrow
- A clinically-relevant STING agonist restrains human TH17 cell inflammatory profile
- Cinnamoyloxy-mammeisin, a coumarin from propolis of stingless bees, attenuates Th17 cell differentiation and autoimmune inflammation via STAT3 inhibition
- Toll-like receptor 9 activation in neutrophils impairs chemotaxis and reduces sepsis outcome
- Superoxide anion-induced pain and inflammation depends on TNFα/TNFR1 signaling in mice
- The citrus flavanone naringenin reduces gout-induced joint pain and inflammation in mice by inhibiting the activation of NFκB and macrophage release of IL-1β
- Trans-chalcone attenuates pain and inflammation in experimental acute gout arthritis in mice
- Hesperidin methylchalcone suppresses experimental gout arthritis in mice by inhibiting NF-KB activation
- Toll like receptor 9 deficiency in neutrophil improves sepsis outcome preventing down-regulation of CXCR2
- Splenectomy increases neutrophil migration but does not affect mortality in lethal sepsis
Informações sobre o DOI: 10.1016/j.celrep.2022.110838 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003155010.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
